BE622943A - Compositions thérapeutiques, contenant des dérivés d'émétine. - Google Patents
Compositions thérapeutiques, contenant des dérivés d'émétine.Info
- Publication number
- BE622943A BE622943A BE622943A BE622943A BE622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A
- Authority
- BE
- Belgium
- Prior art keywords
- therapeutic compositions
- emetine
- derivatives
- emetine derivatives
- therapeutic
- Prior art date
Links
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical class N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
- C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
- C07D455/08—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems having an isoquinolyl-1, a substituted isoquinolyl-1 or an alkylenedioxyisoquinolyl-1 radical linked through only one carbon atom, attached in position 2, e.g. emetine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/26—Removing halogen atoms or halogen-containing groups from the molecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB35268/61A GB982150A (en) | 1961-09-29 | 1961-09-29 | Therapeutic resin complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE622943A true BE622943A (fr) | 1963-01-16 |
Family
ID=10375806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE622943A BE622943A (fr) | 1961-09-29 | 1962-09-27 | Compositions thérapeutiques, contenant des dérivés d'émétine. |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE622943A (fr) |
| FR (1) | FR2489M (fr) |
| GB (1) | GB982150A (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
| FI65910C (fi) * | 1976-11-26 | 1984-08-10 | Pennwalt Corp | Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan |
| US4859462A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Polymer-treated ion exchange resins |
| US4859461A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Coatable ion exchange resins |
| NZ219925A (en) * | 1986-07-30 | 1989-06-28 | Pennwalt Corp | Polymer-treated sulphonic acid cationic exchange resin particles |
| IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
| CA2002492A1 (fr) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Compose pharmaceutique contenant une resine echangeuse d'ions |
| WO2006081518A2 (fr) * | 2005-01-28 | 2006-08-03 | Collegium Pharmaceutical, Inc. | Excipients non aqueux non ioniques pour administration topique et par voie orale d'agents actifs lies a un support |
-
1961
- 1961-09-29 GB GB35268/61A patent/GB982150A/en not_active Expired
-
1962
- 1962-09-27 BE BE622943A patent/BE622943A/fr unknown
- 1962-09-28 FR FR910733A patent/FR2489M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB982150A (en) | 1965-02-03 |
| FR2489M (fr) | 1964-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE622943A (fr) | Compositions thérapeutiques, contenant des dérivés d'émétine. | |
| FR2144M (fr) | Compositions pharmaceutiques contenant des sources radioactives. | |
| DK103662C (da) | Herreunderbenklæder. | |
| FR1902M (fr) | Nouveaux médicaments dérivés de l'isothiazole. | |
| FR2517M (fr) | Compositions pharmaceutiques contenant des propanolamines. | |
| FR6247M (fr) | Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes. | |
| FR2075M (fr) | Nouveaux dérivés de la 6-méthyl- et de la 1,6-diméthyl-ergoline i. | |
| BE601304A (fr) | Compositions stables contenant de l'isoprotéronol. | |
| FR2247M (fr) | Nouvelles compositions médicamenteuses contre l'aphte. | |
| FR2477M (fr) | Dérivés aminés des n-cyclopropylbenzylamines. | |
| BE626351A (fr) | Compositions contenant une 2,6-dichlorobenzamidine comme ingrédient actif | |
| FR3173M (fr) | Dérivés thérapeutiques d'aralcoyl-2-mercapto-benzazoles. | |
| FR2849M (fr) | Composition pour soins dentaires. | |
| FR3461M (fr) | Nouvelles compositions médicamenteuses contenant des dérivés de l'acétyl-glutamine. | |
| FR2260M (fr) | Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant. | |
| BE619267A (fr) | Dérivés d'algines dépolymérisées. | |
| FR2985M (fr) | Compositions pharmaceutiques contenant des dérivés de l'indole. | |
| FR2395M (fr) | Compositions thérapeutiques contenant du 3,5-diméthylisoxazole. | |
| FR2156M (fr) | Nouvelles compositions thérapeutiques. | |
| FR1722M (fr) | Médicaments nouveaux constitués par des 4-(pyridoylamido-acylamino)-1-phényl-2,3-diméthyl-pyrazolones-(5). | |
| FR1373M (fr) | Composition thérapeutique. | |
| OA00656A (fr) | Compositions contenant des dérivés alkylés de la phlorophénone. | |
| FR2398M (fr) | Compositions provoquant l'anorexie. | |
| BE585967A (fr) | Compositions pharmaceutiques contenant des dérivés de la benzylhydrazine. | |
| FR1777M (fr) | Médicament contenant des préparations contre l'hypertension. |